Fortress Biotech - FBIO Short Interest Ratio & Short Volume

Short interest is the volume of Fortress Biotech shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 328,800 shares of FBIO short. 0.51% of Fortress Biotech's shares are currently sold short. Learn More on Fortress Biotech's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fortress Biotech: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.51% of Fortress Biotech's floating shares are currently sold short.

Fortress Biotech saw a decrease in short interest during the month of February. As of February 28th, there was short interest totaling 328,800 shares, a decrease of 22.1% from the previous total of 422,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Fortress Biotech currently has issued a total of 113,440,000 shares. Some of Fortress Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fortress Biotech currently has a public float of 64,380,000 shares.

0.51% of Fortress Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Fortress Biotech: Verastem, Inc. (0.58%), Bolt Biotherapeutics, Inc. (6.23%), Spectrum Pharmaceuticals, Inc. (2.25%), Merrimack Pharmaceuticals, Inc. (7.65%), XOMA Co. (3.83%), Rigel Pharmaceuticals, Inc. (4.41%), Xilio Therapeutics, Inc. (0.44%), VBI Vaccines Inc. (5.68%), Reviva Pharmaceuticals Holdings, Inc. (3.85%), and vTv Therapeutics Inc. (4.10%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks.

Short selling FBIO is an investing strategy that aims to generate trading profit from Fortress Biotech as its price is falling. FBIO shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Fortress Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FBIO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBIO, twice per month. The most recent reporting period available is February, 28 2023.